Dr. Reddy’s Laboratories launches antimuscarinic drug Toviaz generic in US

TAGS

Dr. Reddy’s Laboratories has launched Dr. Reddy’s Fesoterodine Fumarate Extended-Release Tablets in the US market following the approval of the US Food and Drug Administration (FDA).

The product is generic of Toviaz (fesoterodine fumarate) Extended-Release Tablets of Pfizer, an antimuscarinic drug used for the treatment of certain bladder problems.

Dr. Reddy’s Laboratories launches antimuscarinic drug Toviaz generic in US

Dr. Reddy’s Laboratories launches antimuscarinic drug Toviaz generic in US. Photo courtesy of Karthikndr/Wikimedia Commons.

According to IQVIA, the Toviaz brand had sales of nearly $211 million MAT in the US for the most recent 12 months ending in May 2022.

See also  Zydus Lifesciences bags FDA final approval for Tavaborole Topical Solution

Dr. Reddy’s Fesoterodine Fumarate Extended-Release Tablets come in 4mg and 8mg tablets, each in bottle count sizes of 30.

CATEGORIES
TAGS
Share This